dc.contributorUniversidade Federal de São Carlos (UFSCar)
dc.contributorUniversidade Federal de Ouro Preto
dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:00:54Z
dc.date.available2018-12-11T17:00:54Z
dc.date.created2018-12-11T17:00:54Z
dc.date.issued2016-01-01
dc.identifierJournal of the Brazilian Chemical Society, v. 27, n. 1, p. 30-40, 2016.
dc.identifier1678-4790
dc.identifier0103-5053
dc.identifierhttp://hdl.handle.net/11449/172549
dc.identifier10.5935/0103-5053.20150237
dc.identifierS0103-50532016000100030
dc.identifier2-s2.0-84958522271
dc.identifierS0103-50532016000100030.pdf
dc.description.abstractThe [Ru(Spym)(bipy)(P-P)]PF6, [Spym = pyrimidine-2-thiolate anion; P-P = 1,2-bis(diphenylphosphino)ethane, 1,3-bis(diphenylphosphino)propane and 1,1'-bis(diphenylphosphino)ferrocene] complexes were synthesized and characterized by spectroscopic, electrochemical and elemental analysis, and by X-ray crystallography. The minimal inhibitory concentration (MIC) of the compounds against Mycobacterium tuberculosis and the complex concentration causing 50% tumor cell growth inhibition (IC50) against breast cancer cells, MDA-MB-231, were determined. All three compounds gave promising values in both tests. It is interesting to mention that all three complexes display MICs against Mycobacterium tuberculosis showing higher activity than cycloserine, a second line drug used in the treatment of the illness. The complexes interact weakly with the DNA.
dc.languageeng
dc.relationJournal of the Brazilian Chemical Society
dc.relation0,357
dc.relation0,357
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectCytotoxity
dc.subjectDiphosphine ligand
dc.subjectPyrimidine-2-thiolate
dc.subjectRuthenium complexes
dc.subjectTuberculosis
dc.titleAnti-mycobacterium tuberculosis and cytotoxicity activities of ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate complexes: The role of the non-coordinated n-atom
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución